Research Articles

February 15, 2021

Chronic Viral Encephalopathy Mistaken for Schizophrenia

16-Year-Old Boy Lost Psychiatric Symptoms After Antiviral Treatment A recent case report published in the British Medical Journal features the account of a teenage boy who had been experiencing symptoms of paranoid ideation, anxiety, fear and hallucinations for a period of three months. A psychiatric hospital diagnosed the teen with schizophrenia and prescribed the antipsychotic […]

February 15, 2021

Decreased Phenol Sulfotransferase Linked to Common Autism Biomarker

Hyperserotonemia Has Been Associated with ASD for Decades for Unknown Reasons Until Now Hyperserotonemia is the state of increased whole blood serotonin within the body. The condition is the most replicated biochemical abnormality associated with autism spectrum disorders (ASD). The etiology of this biomarker was poorly understood until now. A new French study published in […]

February 15, 2021

Another Suramin Study Shows Promise for Treating Core Symptoms of Autism

Research Involved an Intravenous Form of Suramin Called PAX-101 Exciting news surrounding a potential autism medication was delivered from New Jersey last week. PaxMedica, a biopharmaceutical company, announced impressive results from their phase 2 dose-ranging clinical trial investigating their product PAX-101 (IV suramin) as a potential therapeutic to alleviate core symptoms of autism spectrum disorder […]

February 15, 2021

Most Medical Doctors View the Lives of Individuals with Disabilities as Subpar

Lead Author of New Study Calls Findings, “Very Disturbing”  Approximately 12% of  Americans have at least one disability. Growing evidence shows that individuals living with disabilities experience healthcare disparities compared to the general population. A new study published in the journal Health Affairs was the first of its kind to examine doctors’ attitudes on treating […]

February 08, 2021

Psilocybin May Become a Future Autism Treatment

Psychedelics Show Promise for Treating Neuropsychiatric Disorders  Psilocybin is a hallucinogenic/psychedelic substance that works by activating serotonin receptors in the prefrontal cortex, the area of the brain that affects mood, cognition, and perception. Recently, psychedelics have shown acceptable safety and efficacy in treating various neuropsychiatric disorders. They have also demonstrated sustained prosocial behavior and helped […]

February 08, 2021

Newly Licensed Drivers with Autism Have Better Driving Records Than Neurotypical Peers

However, Additional Road Training May Benefit Drivers with ASD  A new study has found that young drivers with autism have lower rates of moving violations, license suspensions and crash rates compared to their neurotypical peers. This research was produced by a collaboration between the Center for Injury Research and Prevention (CIRP) and the Center for […]

Show Buttons
Hide Buttons